The trial of VB-601 may add value but hiring an advisor for ...
The trial of VB-601 may add value but hiring an advisor for strategic options and reporting losses indicate resource pressure and strategy shift, thus casting doubt on future performance.
Press Release: VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3989Followers
0Following
8967Visitors
Follow